BioSpace News Archive

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced plans today to launch a patient- and physician-reported outcomes data warehouse - the Duchenne Outcomes Research Interchange (the Interchange) - which will combine data from The Duchenne Registr

Le-Vel, the world leader in human nutritional innovation, is thrilled to announce that the company is now fully operational in Canada.

On June 19th, 2018, Canada had passed a nationwide legalization of recreational cannabis usage, following Uruguay to become just the second nation to do so

Data compiled by Grand View Research indicates that the global biotechnology market is expected to reach USD 727.1 Billion by 2025.

According to a report published by Global Market Insights, the U.S medical cannabis market size was valued at over USD 3.5 Billion in 2017 and is expected to exceed USD 8.0 Billion by 2024 while growing at a compound annual growth rate (CAGR) of 13%.

Quantum Leap Healthcare Collaborative (QLHC) announce their upcoming press conference on September 12, 2018 at the National Press Club in Washington, DC. A press release on September 12 will precede the press event.

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug administration for the store brand over-the-counter (OTC) equivalent of Imodium® Multi-Symptom Relief (loperamide hydrochloride and simethicone tablets, 2 mg/125 mg)

Novus Therapeutics Inc today announced that it has elected to postpone the previously announced public offering of its common stock due to market conditions

Cryo Innovations, U.S manufacturer of the safest and most technologically advanced whole-body cryotherapy chamber, was seen yesterday on The Ellen DeGeneres Show when their XR Chamber was used to run a live cryotherapy session.

Advaxis, Inc. announce today the pricing of an underwritten public offering of 16,666,666 shares of its common stock and warrants to purchase up to 14,666,666 shares of common stock.